We are international
Donate
• health professionals TEXT SIZE   
webcasts    back

Bortezomib as First-Line Therapy in Patients with MM; A Multicenter Phase 2 Clinical Trial
By Sundar Jagannath, MD
12.12.04
Interview with Dr. Jagannath


 related articles